Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-27FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin from Accord Healthcare, Inc., finalizing the regulatory action for this generic prod…
-
FDA label_change · 2013-01-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Metabolic Health Benefits of Dairy Protein [Phase 1]
Phase 1 trial evaluating metabolic health benefits of dairy protein in individuals with hyperlipidemia and obesity. The study is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic study of a Livalo fixed-dose combination containing pitavastatin in healthy subjects; the trial has completed.
-
FDA approval · 2012-12-31FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Fluvastatin from Teva Pharmaceuticals USA, Inc. to update the product labeling (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for pravastatin sodium, a generic statin, reflecting an approved update for this…
-
FDA approval · 2012-12-29FDA Approved: SIMVASTATIN — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Simvastatin submitted by Micro Labs Limited.
-
FDA approval · 2012-12-29FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, enabling continued marketing of the …
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluated the efficacy and safety of fermented barley for reducing body fat in overweight/obese adults w…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Clinical trial update assessing how genetic factors influence rosuvastatin therapy in hyperlipidemia. The study is sponsored by National Tai…
-
FDA approval · 2012-12-19FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate, updating the product labeling and/or approvals under a sup…
-
CLINICAL_TRIALS withdrawal · 2012-12-19Clinical Trial Update: Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART [NA]
This clinical trial evaluated a mixed exercise regime combined with L-Carnitine supplementation in HIV patients on HAART. The study has been…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) [Phase 1]
This document reports a Phase 1 relative bioavailability study comparing Lipidil Supra (fenofibrate 160 mg) to SYO-0805 (fenofibrate 65 mg).…
-
FDA approval · 2012-12-07FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for fenofibrate, enabling the marketing of a generic fenofibrate product.
-
FDA approval · 2012-11-30FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
FDA approved Lipitor (atorvastatin calcium) under a supplemental application submitted by Viatris Specialty LLC.
-
FDA approval · 2012-11-30FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lovastatin from Lupin Pharmaceuticals, Inc., under the ANDA program.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids [Phase 2, Phase 3]
This clinical trial update reports on the efficacy and safety of Kochujang Pills in improving blood lipid levels in hyperlipidemia patients …
-
FDA approval · 2012-11-28FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. The approval expands the availab…
-
FDA approval · 2012-11-27FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-11-23FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application to authorize the generic atorvastatin calcium product from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS research · 2012-11-22Clinical Trial Update: Using Learning Teams for Reflective Adaptation for Diabetes and Depression [NA]
A completed clinical trial evaluating the use of learning teams to support reflective adaptation in diabetes and depression care.
-
FDA approval · 2012-11-20FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for simvastatin from Lupin Pharmaceuticals, indicating approval of a generic-simvastatin product via…
-
FDA approval · 2012-11-15FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2012-11-15FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin [Phase 4]
Phase 4 study assessing genetic predictors of variability in the drug-drug interaction between the darunavir/ritonavir combination and prava…